Choice of Capecitabine or S1 in Combination with Oxaliplatin based on Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Expression Status in Patients with Advanced Gastric Cancer

PURPOSE: To study the efficacy of capecitabine or S-1 plus oxaliplatin (CAPOX or SOX) for treating thymidine phosphorylase (TP)- or dihydropyrimidine dehydrogenase (DPD)-positive advanced gastric cancer. MATERIALS AND METHODS: Eighty-six patients with stage IIIC to IV gastric cancer were assessed fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Rong, He, Xiaolei, Wufuli, Reyina, Su, Ying, Ma, Lili, Chen, Ru, Han, Zhongcheng, Wang, Fang, Liu, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928084/
https://www.ncbi.nlm.nih.gov/pubmed/31897343
http://dx.doi.org/10.5230/jgc.2019.19.e40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928084/
https://www.ncbi.nlm.nih.gov/pubmed/31897343
http://dx.doi.org/10.5230/jgc.2019.19.e40

Ejemplares similares